Literature DB >> 22461692

TGF-β converts apoptotic stimuli into the signal for Th9 differentiation.

Mariko Takami1, Robert B Love, Makio Iwashima.   

Abstract

Naturally arising CD4(+)CD25(+)FoxP3(+) regulatory T cells (nTregs) have an essential role in maintenance of immune homeostasis and peripheral tolerance. Previously, we reported that conventional CD4(+) and CD8(+) T cells undergo p53-induced CD28-dependent apoptosis (PICA) when stimulated with a combination of immobilized anti-CD3 and anti-CD28 Abs, whereas nTregs expand robustly under the same conditions, suggesting that there is a differential survival mechanism against PICA between conventional T cells and nTregs. In this study, we demonstrate that TGF-β signaling is required for nTregs to survive PICA. Conversely, when an active form of exogenous TGF-β is present, conventional T cells become resistant to PICA and undergo robust expansion instead of apoptosis, with reduction of the proapoptotic protein Bim and FoxO3a. A substantial fraction of PICA-resistant T cells expressed IL-9 (T(H)9 cells). Moreover, the presence of IL-6 along with TGF-β led to the generation of T(H)17 cells from conventional T cells. Together, the data demonstrate a novel role for TGF-β in the homeostasis of regulatory T cells and effector T cell differentiation and expansion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461692      PMCID: PMC3331903          DOI: 10.4049/jimmunol.1102698

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

Authors:  Li Yang; Yanli Pang; Harold L Moses
Journal:  Trends Immunol       Date:  2010-06-01       Impact factor: 16.687

Review 2.  Dual role for TGF-beta1 in apoptosis.

Authors:  Amelia Sánchez-Capelo
Journal:  Cytokine Growth Factor Rev       Date:  2005-01-25       Impact factor: 7.638

3.  The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2.

Authors:  Marie Stahl; Pascale F Dijkers; Geert J P L Kops; Susanne M A Lens; Paul J Coffer; Boudewijn M T Burgering; René H Medema
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

4.  Transforming growth factor-beta decreases survival of Mycobacterium bovis-activated T cells.

Authors:  Marisol Hernández-Garay; Patricia Méndez-Samperio
Journal:  Arch Med Res       Date:  2003 Jan-Feb       Impact factor: 2.235

5.  TGF-beta1 inhibits Fas-mediated apoptosis by regulating surface Fas and cFLIPL expression in human leukaemia/lymphoma cells.

Authors:  Young-Joo Jung; Jee-Youn Kim; Jae-Hoon Park
Journal:  Int J Mol Med       Date:  2004-01       Impact factor: 4.101

6.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

7.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

8.  Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.

Authors:  K Nakamura; A Kitani; W Strober
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

9.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  13 in total

Review 1.  IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Authors:  Junhui Li; Shuqiu Chen; Xiang Xiao; Yong Zhao; Wenjun Ding; Xian C Li
Journal:  Cytokine Growth Factor Rev       Date:  2017-07-17       Impact factor: 7.638

Review 2.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

3.  Th2 cells as an intermediate for the differentiation of naïve T cells into Th9 cells, associated with the Smad3/Smad4 and IRF4 pathway.

Authors:  Mohamed Hamed Abdelaziz; Huixuan Wang; Jianjun Cheng; Huaxi Xu
Journal:  Exp Ther Med       Date:  2020-01-03       Impact factor: 2.447

4.  Interleukin 9 alterations linked to alzheimer disease in african americans.

Authors:  Whitney Wharton; Alexander L Kollhoff; Umesh Gangishetti; Danielle D Verble; Samsara Upadhya; Henrik Zetterberg; Veena Kumar; Kelly D Watts; Andrea J Kippels; Marla Gearing; J Christina Howell; Monica W Parker; William T Hu
Journal:  Ann Neurol       Date:  2019-07-22       Impact factor: 10.422

5.  Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers.

Authors:  Yong Lu; Bangxing Hong; Haiyan Li; Yuhuan Zheng; Mingjun Zhang; Siqing Wang; Jianfei Qian; Qing Yi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

6.  Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells.

Authors:  Il-Kyu Kim; Byung-Seok Kim; Choong-Hyun Koh; Jae-Won Seok; Jun-Seok Park; Kwang-Soo Shin; Eun-Ah Bae; Ga-Eun Lee; Hyewon Jeon; Jaebeom Cho; Yujin Jung; Daehee Han; Byoung S Kwon; Ho-Young Lee; Yeonseok Chung; Chang-Yuil Kang
Journal:  Nat Med       Date:  2015-08-17       Impact factor: 53.440

Review 7.  Th9 cells: differentiation and disease.

Authors:  Mark H Kaplan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

Review 8.  Potential of targeting TGF-β for organ transplant patients.

Authors:  Makio Iwashima; Robert Love
Journal:  Future Med Chem       Date:  2013-03       Impact factor: 3.808

9.  TGF-β suppresses RasGRP1 expression and supports regulatory T cell resistance against p53-induced CD28-dependent T-cell apoptosis.

Authors:  Mariko Takami; Christina Cunha; Shinichiro Motohashi; Toshinori Nakayama; Makio Iwashima
Journal:  Eur J Immunol       Date:  2018-10-24       Impact factor: 5.532

Review 10.  Th9 Cell Differentiation and Its Dual Effects in Tumor Development.

Authors:  Tao Chen; Jufeng Guo; Zhenhai Cai; Binghao Li; Lingling Sun; Yingying Shen; Shengdong Wang; Zhan Wang; Zenan Wang; Yucheng Wang; Hao Zhou; Zhijian Cai; Zhaoming Ye
Journal:  Front Immunol       Date:  2020-05-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.